Literature DB >> 26244324

PML in Patients Treated with Dimethyl Fumarate.

Dennis J Nieuwkamp, Jean-Luc Murk, Bob W van Oosten.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26244324     DOI: 10.1056/NEJMc1506151

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  5 in total

1.  Multiple Sclerosis Medications in the VHA: Delivering Specialty, High-Cost, Pharmacy Care in a National System.

Authors:  Kathryn Tortorice; Natasha Antonovich
Journal:  Fed Pract       Date:  2020-04

2.  Donor variability may mask dimethyl fumarate's effects on nuclear factor E2-related factor 2 in human peripheral blood mononuclear cells.

Authors:  Sarah E Fiedler; Amelia R Kerns; Catherine Tsang; Haley N Love; Sonemany Salinthone
Journal:  BMC Res Notes       Date:  2017-11-02

3.  Characterization of myelin oligodendrocyte glycoprotein (MOG)35-55-specific CD8+ T cells in experimental autoimmune encephalomyelitis.

Authors:  Yong Peng; Fei-Zhou Zhu; Zhi-Xing Chen; Jian-Xiong Zhou; Lu Gan; Shan-Shan Yang; Shuai Gao; Qian-Qian Liu
Journal:  Chin Med J (Engl)       Date:  2019-12-20       Impact factor: 2.628

4.  Varicella-Zoster Reactivation in a Non-immunized Elderly Multiple Sclerosis Patient While on Delayed-Release Dimethyl Fumarate With Grade 2 Lymphopenia and Profoundly Low CD4+ and CD8+ Cell Counts: A Case Report.

Authors:  Bob Daripa; Scott Lucchese
Journal:  Cureus       Date:  2022-02-28

5.  Impaired T-cell migration to the CNS under fingolimod and dimethyl fumarate.

Authors:  Amandine Mathias; Sylvain Perriot; Mathieu Canales; Claudia Blatti; Coline Gaubicher; Myriam Schluep; Britta Engelhardt; Renaud Du Pasquier
Journal:  Neurol Neuroimmunol Neuroinflamm       Date:  2017-10-11
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.